Home
About
Services
Partners
Client Portfolio
News
Contact
Exclusive: Hudson’s Bay Co’s take-private deal falls short in shareholder vote – sources
December 14, 2019
China’s Ant Financial, Vanguard announce China advisory venture
December 14, 2019
0
Bristol-Myers wins $752 million in U.S. patent case against Gilead
Published by
Muller&Green
at
December 14, 2019
Categories
RSS
Tags
Bristol-Myers Squibb Co on Friday said it won a $752 million jury verdict against Gilead Sciences Inc in a U.S. patent dispute relating to technology for treating cancer.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more